Diego Vergani

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Disorders

Anatomy

Physiology

Concepts & Ideas

Biological Markers

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Vergani Diego; Longhi Maria Serena; Bogdanos Dimitrios P; Ma Yun; Mieli-Vergani Giorgina
Autoimmune hepatitis.
Mieli-Vergani Giorgina; Vergani Diego
Biliary atresia.
Mieli-Vergani Giorgina; Vergani Diego
Autoimmune hepatitis in children: what is different from adult AIH?

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Diego Vergani (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Vergani Diego; Longhi Maria Serena; Bogdanos Dimitrios P; Ma Yun; Mieli-Vergani Giorgina
Autoimmune hepatitis.
Seminars in immunopathology 2009;31(3):421-35.
2009: Mieli-Vergani Giorgina; Vergani Diego
Biliary atresia.
Seminars in immunopathology 2009;31(3):371-81.
2009: Mieli-Vergani Giorgina; Vergani Diego
Autoimmune hepatitis in children: what is different from adult AIH?
Seminars in liver disease 2009;29(3):297-306.
2009: Bogdanos Dimitrios P; Mieli-Vergani Giorgina; Vergani Diego
Autoantibodies and their antigens in autoimmune hepatitis.
Seminars in liver disease 2009;29(3):241-53.
2009: Mieli-Vergani Giorgina; Heller Solange; Jara Paloma; Vergani Diego; Chang Mei-Hwei; Fujisawa Tomoo; González-Peralta Regino P; Kelly Deirdre; Mohan Neelam; Shah Uzma; Murray Karen F
Autoimmune hepatitis.
Journal of pediatric gastroenterology and nutrition 2009;49(2):158-64.
2009: Longhi Maria Serena; Mitry Ragai R; Samyn Marianne; Scalori Astrid; Hussain Munther J; Quaglia Alberto; Mieli-Vergani Giorgina; Ma Yun; Vergani Diego
Vigorous activation of monocytes in juvenile autoimmune liver disease escapes the control of regulatory T-cells.
Hepatology (Baltimore, Md.) 2009;50(1):130-42.
2009: Bogdanos Dimitrios P; Vergani Diego
Bacteria and primary biliary cirrhosis.
Clinical reviews in allergy & immunology 2009;36(1):30-9.
2008: Antoniades Charalambos Gustav; Berry Philip A; Wendon Julia A; Vergani Diego
The importance of immune dysfunction in determining outcome in acute liver failure.
Journal of hepatology 2008;49(5):845-61.
2008: Bogdanos Dimitrios; Pusl Thomas; Rust Christian; Vergani Diego; Beuers Ulrich
Primary biliary cirrhosis following Lactobacillus vaccination for recurrent vaginitis.
Journal of hepatology 2008;49(3):466-73.
2008: Bogdanos Dimitrios-P; Invernizzi Pietro; Mackay Ian-R; Vergani Diego
Autoimmune liver serology: current diagnostic and clinical challenges.
World journal of gastroenterology : WJG 2008;14(21):3374-87.
2008: Mieli-Vergani Giorgina; Vergani Diego
Autoimmune paediatric liver disease.
World journal of gastroenterology : WJG 2008;14(21):3360-7.
2008: Vergani Diego; Mieli-Vergani Giorgina
Aetiopathogenesis of autoimmune hepatitis.
World journal of gastroenterology : WJG 2008;14(21):3306-12.
2008: Vergani Diego; Mieli-Vergani Giorgina
Autoimmune Hepatitis and PSC Connection.
Clinics in liver disease 2008;12(1):187-202, x.
2008: Longhi Maria Serena; Meda Francesca; Wang Pengyun; Samyn Marianne; Mieli-Vergani Giorgina; Vergani Diego; Ma Yun
Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis.
Hepatology (Baltimore, Md.) 2008;47(2):581-91.
2008: Cross Timothy J S; Rizzi Paolo; Horner Mary; Jolly Anita; Hussain Munther J; Smith Heather M; Vergani Diego; Harrison Phillip M
The increasing prevalence of hepatitis delta virus (HDV) infection in South London.
Journal of medical virology 2008;80(2):277-82.
2007: Rigopoulou Eirini I; Davies Edward T; Bogdanos Dimitrios-Petrou; Liaskos Christos; Mytilinaiou Maria; Koukoulis George K; Dalekos George N; Vergani Diego
Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis.
Liver international : official journal of the International Association for the Study of the Liver 2007;27(9):1226-31.
2007: Bernal William; Ma Yun; Smith Heather M; Portmann Bernard; Wendon Julia; Vergani Diego
The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study.
Journal of hepatology 2007;47(5):664-70.
2007: Antoniades Charalambos G; Berry Philip A; Bruce Matthew; Cross Timothy J S; Portal Andrew J; Hussain Munther J; Bernal William; Wendon Julia A; Vergani Diego
Actin-free Gc globulin: a rapidly assessed biomarker of organ dysfunction in acute liver failure and cirrhosis.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2007;13(9):1254-61.
2007: Longhi Maria Serena; Hussain Munther J; Bogdanos Dimitrios P; Quaglia Alberto; Mieli-Vergani Giorgina; Ma Yun; Vergani Diego
Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2.
Hepatology (Baltimore, Md.) 2007;46(2):472-84.
2007: Bogdanos Dimitrios P; Liaskos Christos; Pares Albert; Norman Gary; Rigopoulou Eirini I; Caballeria Llorenç; Dalekos George N; Rodes Juan; Vergani Diego
Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis.
Hepatology (Baltimore, Md.) 2007;45(6):1583; author reply 1583-4.
2007: Vergani Diego; Mieli-Vergani Giorgina
The impact of autoimmunity on hepatocytes.
Seminars in liver disease 2007;27(2):140-51.
2007: Rigopoulou Eirini I; Bogdanos Dimitrios-Petrou; Liaskos Christos; Koutsoumpas Andreas; Baum Harold; Vergani Diego; Dalekos George N
Anti-mitochondrial antibody immunofluorescent titres correlate with the number and intensity of immunoblot-detected mitochondrial bands in patients with primary biliary cirrhosis.
Clinica chimica acta; international journal of clinical chemistry 2007;380(1-2):118-21.
2007: Muiesan Paolo; Vergani Diego; Mieli-Vergani Giorgina
Liver transplantation in children.
Journal of hepatology 2007;46(2):340-8.
2006: Bogdanos D-P; Koutsoumpas A; Baum H; Vergani D
Borrelia Burgdorferi: a new self-mimicking trigger in primary biliary cirrhosis.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2006;38(10):781-2; author reply 782-3.
2006: Polymeros Dimitrios; Bogdanos Dimitrios P; Day Richard; Arioli Dimitryi; Vergani Diego; Forbes Alastair
Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease?
Gastroenterology 2006;131(1):85-96.
2006: Antoniades Charalambos Gustav; Berry Philip A; Davies Edward T; Hussain Munther; Bernal William; Vergani Diego; Wendon Julia
Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure.
Hepatology (Baltimore, Md.) 2006;44(1):34-43.
2006: Longhi Maria Serena; Hussain Munther J; Mitry Ragai R; Arora Sunil K; Mieli-Vergani Giorgina; Vergani Diego; Ma Yun
Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(7):4484-91.
2006: Ma Yun; Bogdanos Dimitrios P; Hussain Munther J; Underhill James; Bansal Sanjay; Longhi Maria Serena; Cheeseman Paul; Mieli-Vergani Giorgina; Vergani Diego
Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2.
Gastroenterology 2006;130(3):868-82.
2006: D'Antiga Lorenzo; Aw Marion; Atkins Mark; Moorat Alison; Vergani Diego; Mieli-Vergani Giorgina
Combined lamivudine/interferon-alpha treatment in "immunotolerant" children perinatally infected with hepatitis B: a pilot study.
The Journal of pediatrics 2006;148(2):228-233.
2005: Bogdanos Dimitrios-Petrou; Smith Heather; Ma Yun; Baum Harold; Mieli-Vergani Giorgina; Vergani Diego
A study of molecular mimicry and immunological cross-reactivity between hepatitis B surface antigen and myelin mimics.
Clinical & developmental immunology 2005;12(3):217-24.
2005: Bogdanos Dimitrios-Petrou; Baum Harold; Okamoto Manabu; Montalto Paolo; Sharma Umesh C; Rigopoulou Eirini I; Vlachogiannakos John; Ma Yun; Burroughs Andrew K; Vergani Diego
Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic.
Hepatology (Baltimore, Md.) 2005;42(2):458-65.
2005: Longhi Maria Serena; Ma Yun; Mitry Ragai R; Bogdanos Dimitrios P; Heneghan Michael; Cheeseman Paul; Mieli-Vergani Giorgina; Vergani Diego
Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis.
Journal of autoimmunity 2005;25(1):63-71.
2005: Rigopoulou E I; Davies E T; Pares A; Zachou K; Liaskos C; Bogdanos D-P; Rodes J; Dalekos G N; Vergani D
Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis.
Gut 2005;54(4):528-32.
2005: Antoniades Charalambos Gustav; Wendon Julia; Vergani Diego
Paralysed monocytes in acute on chronic liver disease.
Journal of hepatology 2005;42(2):163-5.
2005: Ma Y; Meregalli M; Hodges S; Davies N; Bogdanos D P; Fargion S; Fiorelli G; Vergani D
Alcohol dehydrogenase: an autoantibody target in patients with alcoholic liver disease.
International journal of immunopathology and pharmacology 2005;18(1):173-82.
2004: Vergani Diego; Mieli-Vergani Giorgina
Mechanisms of autoimmune hepatitis.
Pediatric transplantation 2004;8(6):589-93.
2004: Bogdanos D-P; Baum H; Gunsar F; Arioli D; Polymeros D; Ma Y; Burroughs A K; Vergani D
Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross-reactivity.
Scandinavian journal of gastroenterology 2004;39(10):981-7.
2004: Vergani Diego; Alvarez Fernando; Bianchi Francesco B; Cançado Eduardo L R; Mackay Ian R; Manns Michael P; Nishioka Mikio; Penner Edward;
Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group.
Journal of hepatology 2004;41(4):677-83.
2004: Longhi Maria Serena; Ma Yun; Bogdanos Dimitrios P; Cheeseman Paul; Mieli-Vergani Giorgina; Vergani Diego
Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease.
Journal of hepatology 2004;41(1):31-7.
2004: Vergani D; Mieli-Vergani G
Autoimmune hepatitis.
Minerva gastroenterologica e dietologica 2004;50(2):113-23.
2004: Vergani Diego; Mieli-Vergani Giorgina
Autoimmune hepatitis and sclerosing cholangitis.
Autoimmunity 2004;37(4):329-32.
2004: Bogdanos Dimitrios-Petrou; Pares Albert; Baum Harold; Caballeria Llorenc; Rigopoulou Eirini I; Ma Yun; Burroughs Andrew K; Rodes Juan; Vergani Diego
Disease-specific cross-reactivity between mimicking peptides of heat shock protein of Mycobacterium gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosis.
Journal of autoimmunity 2004;22(4):353-62.
2004: Bogdanos Dimitrios-Petrou; Pares Albert; Rodés Juan; Vergani Diego
Primary biliary cirrhosis specific antinuclear antibodies in patients from Spain.
The American journal of gastroenterology 2004;99(4):763-4; author reply 765.
2004: Vergani Diego; Bogdanos Dimitrios-Petrou; Baum Harold
Unusual suspects in primary biliary cirrhosis.
Hepatology (Baltimore, Md.) 2004;39(1):38-41.
2004: Bogdanos Dimitrios-Petrou; Baum Harold; Grasso Alessandro; Okamoto Manabu; Butler Patrice; Ma Yun; Rigopoulou Eirini; Montalto Paolo; Davies Edward T; Burroughs Andrew K; Vergani Diego
Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis.
Journal of hepatology 2004;40(1):31-9.
2003: Bogdanos D P; Baum H; Butler P; Rigopoulou E I; Davies E T; Ma Y; Burroughs A K; Vergani D
Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2003;35(11):801-5.
2003: Bogdanos Dimitrios-Petrou; Baum Harold; Vergani Diego
Antimitochondrial and other autoantibodies.
Clinics in liver disease 2003;7(4):759-77, vi.
2003: Vergani Diego; Mieli-Vergani Giorgina
Autoimmune hepatitis.
Autoimmunity reviews 2003;2(5):241-7.
2003: Gregorio G V; Choudhuri K; Ma Y; Pensati P; Iorio R; Grant P; Garson J; Bogdanos D P; Vegnente A; Mieli-Vergani G; Vergani D
Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection.
Clinical and experimental immunology 2003;133(3):404-13.
2003: Mieli-Vergani G; Vergani D
Autoimmune liver disease in children.
Annals of the Academy of Medicine, Singapore 2003;32(2):239-43.
2003: Kerkar Nanda; Choudhuri Kaushik; Ma Yun; Mahmoud Ayman; Bogdanos Dimitrios P; Muratori Luigi; Bianchi Francesco; Williams Roger; Mieli-Vergani Giorgina; Vergani Diego
Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(3):1481-9.
2002: Hannam Simon; Bogdanos Dimitrios-Petrou; Davies Edward T; Hussain Munther J; Portmann Bernard C; Mieli-Vergani Giorgina; Vergani Diego
Neonatal liver disease associated with placental transfer of anti-mitochondrial antibodies.
Autoimmunity 2002;35(8):545-50.
2002: Gregorio Germana V; McFarlane Barbara; Bracken Paul; Vergani Diego; Mieli-Vergani Giorgina
Organ and non-organ specific autoantibody titres and IgG levels as markers of disease activity: a longitudinal study in childhood autoimmune liver disease.
Autoimmunity 2002;35(8):515-9.
2002: Kerkar N; Ma Y; Davies E T; Cheeseman P; Mieli-Vergani G; Vergani D
Detection of liver kidney microsomal type 1 antibody using molecularly based immunoassays.
Journal of clinical pathology 2002;55(12):906-9.
2002: Vergani Diego; Choudhuri Kaushik; Bogdanos Dimitrios P; Mieli-Vergani Giorgina
Pathogenesis of autoimmune hepatitis.
Clinics in liver disease 2002;6(3):727-37.
2002: Vergani Diego; Mieli-Vergani Giorgina
Autoimmunity after liver transplantation.
Hepatology (Baltimore, Md.) 2002;36(2):271-6.
2002: Ma Yun; Thomas Mark G; Okamoto Manabu; Bogdanos Dimitrios P; Nagl Sylvia; Kerkar Nanda; Lopes Agnel R; Muratori Luigi; Lenzi Marco; Bianchi Francesco B; Mieli-Vergani Giorgina; Vergani Diego
Key residues of a major cytochrome P4502D6 epitope are located on the surface of the molecule.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(1):277-85.
2002: Ma Yun; Okamoto Manabu; Thomas Mark G; Bogdanos Dimitrios P; Lopes Agnel R; Portmann Bernard; Underhill James; Dürr Ralf; Mieli-Vergani Giorgina; Vergani Diego
Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease.
Hepatology (Baltimore, Md.) 2002;35(3):658-64.
2002: Mieli-Vergani Giorgina; Vergani Diego
Autoimmune liver disease.
Indian journal of pediatrics 2002;69(1):93-8.
2002: Bogdanos Dimitrios-Petrou; Baum Harold; Sharma Umesh C; Grasso Alessandro; Ma Yun; Burroughs Andrew K; Vergani Diego
Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis.
Journal of hepatology 2002;36(1):14-21.
2001: Ma Y; Fracanzani A L; Sampietro M; Mattioli M; Cheeseman P; Williams R; Mieli-Vergani G; Vergani D; Fargion S
Autoantibodies to human cytosol: a marker of sporadic porphyria cutanea tarda.
Clinical and experimental immunology 2001;126(1):47-53.
2001: Bogdanos D P; Choudhuri K; Vergani D
Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences.
Liver 2001;21(4):225-32.
2001: Baum H; Bogdanos D P; Vergani D
Antibodies to Clp protease in primary biliary cirrhosis: possible role of a mimicking T-cell epitope.
Journal of hepatology 2001;34(5):785-7.
2001: Gregorio G V; Portmann B; Karani J; Harrison P; Donaldson P T; Vergani D; Mieli-Vergani G
Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study.
Hepatology (Baltimore, Md.) 2001;33(3):544-53.
2000: Webster G J; Reignat S; Maini M K; Whalley S A; Ogg G S; King A; Brown D; Amlot P L; Williams R; Vergani D; Dusheiko G M; Bertoletti A
Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms.
Hepatology (Baltimore, Md.) 2000;32(5):1117-24.
2000: Bogdanos D P; Mieli-Vergani G; Vergani D
Virus, liver and autoimmunity.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2000;32(5):440-6.
2000: Maini M K; Boni C; Lee C K; Larrubia J R; Reignat S; Ogg G S; King A S; Herberg J; Gilson R; Alisa A; Williams R; Vergani D; Naoumov N V; Ferrari C; Bertoletti A
The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection.
The Journal of experimental medicine 2000;191(8):1269-80.
2000: Vergani D
LKM antibody: getting in some target practice.
Gut 2000;46(4):449-50.
1999: Maini M K; Boni C; Ogg G S; King A S; Reignat S; Lee C K; Larrubia J R; Webster G J; McMichael A J; Ferrari C; Williams R; Vergani D; Bertoletti A
Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection.
Gastroenterology 1999;117(6):1386-96.
1999: Ejskjaer N; Arif S; Dodds W; Zanone M M; Vergani D; Watkins P J; Peakman M
Prevalence of autoantibodies to autonomic nervous tissue structures in Type 1 diabetes mellitus.
Diabetic medicine : a journal of the British Diabetic Association 1999;16(7):544-9.
1999: Nagata I; Colucci G; Gregorio G V; Cheeseman P; Williams R; Mieli-Vergani G; Vergani D
The role of HBV DNA quantitative PCR in monitoring the response to interferon treatment in chronic hepatitis B virus infection.
Journal of hepatology 1999;30(6):965-9.
1999: Xu X J; Gearon C; Stevens E; Vergani D; Baum H; Peakman M
Spontaneous T-cell proliferation in the non-obese diabetic mouse to a peptide from the unique class II MHC molecule, I-Ag7, which is also protective against the development of autoimmune diabetes.
Diabetologia 1999;42(5):560-5.
1999: Kerkar N; Ma Y; Hussain M; Muratori L; Targett C; Williams R; Bianchi F B; Mieli-Vergani G; Vergani D
A novel assay for detecting antibodies to cytochrome P4502D6, the molecular target of liver kidney microsomal antibody type 1.
Journal of immunological methods 1999;223(2):227-35.
1999: Gregorio G V; Choudhuri K; Ma Y; Vegnente A; Mieli-Vergani G; Vergani D
Mimicry between the hepatitis B virus DNA polymerase and the antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis B virus infection.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(3):1802-10.
1998: Choudhuri K; Vergani D
MHC restriction to T-cell autoaggression: an emerging understanding of IDDM pathogenesis.
Diabetes/metabolism reviews 1998;14(4):285-301.
1998: Pelli N; Fensom A H; Slade C; Boa F; Mieli-Vergani G; Vergani D
Argininosuccinate lyase: a new autoantigen in liver disease.
Clinical and experimental immunology 1998;114(3):455-61.
1998: Choudhuri K; Gregorio G V; Mieli-Vergani G; Vergani D
Immunological cross-reactivity to multiple autoantigens in patients with liver kidney microsomal type 1 autoimmune hepatitis.
Hepatology (Baltimore, Md.) 1998;28(5):1177-81.
1998: Gregorio G V; Pensati P; Iorio R; Vegnente A; Mieli-Vergani G; Vergani D
Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection.
Clinical and experimental immunology 1998;112(3):471-6.
1998: Vergani D; Gregorio G V; Choudhuri K; Ma Y; Vegnente A; Mieli-Vergani G
Hepatitis virus induced autoimmunity.
Acta gastro-enterologica Belgica 1998;61(2):217-8.
1998: Hussain M J; Maher J; Warnock T; Vats A; Peakman M; Vergani D
Cytokine overproduction in healthy first degree relatives of patients with IDDM.
Diabetologia 1998;41(3):343-9.
1998: Kerkar N; Hadzic N; Davies E T; Portmann B; Donaldson P T; Rela M; Heaton N D; Vergani D; Mieli-Vergani G
De-novo autoimmune hepatitis after liver transplantation.
Lancet 1998;351(9100):409-13.
1998: Mieli-Vergani G; Vergani D
Immunological liver diseases in children.
Seminars in liver disease 1998;18(3):271-9.
1997: Gearon C L; Hussain M J; Vergani D; Peakman M
Lymphocyte vaccination protects prediabetic non-obese diabetic mice from developing diabetes mellitus.
Diabetologia 1997;40(12):1388-95.
1997: Maule S; Quadri R; Mirante D; Pellerito R A; Marucco E; Marinone C; Vergani D; Chiandussi L; Zanone M M
Autonomic nervous dysfunction in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA): possible pathogenic role of autoantibodies to autonomic nervous structures.
Clinical and experimental immunology 1997;110(3):423-7.
1997: Gregorio G V; Portmann B; Mowat A P; Vergani D; Mieli-Vergani G
A 12-year-old girl with antimitochondrial antibody-positive autoimmune hepatitis.
Journal of hepatology 1997;27(4):751-4.
1997: Zanone M M; Petersen J S; Vergani D; Peakman M
Expression of glutamic acid decarboxylase in nervous tissue structures targeted by autoantibodies in patients with diabetic autonomic neuropathy.
Journal of neuroimmunology 1997;78(1-2):1-7.
1997: Cachia M J; Peakman M; Zanone M; Watkins P J; Vergani D
Reproducibility and persistence of neural and adrenal autoantibodies in diabetic autonomic neuropathy.
Diabetic medicine : a journal of the British Diabetic Association 1997;14(6):461-5.
1997: Ma Y; Gregorio G; Gäken J; Muratori L; Bianchi F B; Mieli-Vergani G; Vergani D
Establishment of a novel radioligand assay using eukaryotically expressed cytochrome P4502D6 for the measurement of liver kidney microsomal type 1 antibody in patients with autoimmune hepatitis and hepatitis C virus infection.
Journal of hepatology 1997;26(6):1396-402.
1997: Gregorio G V; Portmann B; Reid F; Donaldson P T; Doherty D G; McCartney M; Mowat A P; Vergani D; Mieli-Vergani G
Autoimmune hepatitis in childhood: a 20-year experience.
Hepatology (Baltimore, Md.) 1997;25(3):541-7.
1997: Ma Y; Gäken J; McFarlane B M; Foss Y; Farzaneh F; McFarlane I G; Mieli-Vergani G; Vergani D
Alcohol dehydrogenase: a target of humoral autoimmune response in liver disease.
Gastroenterology 1997;112(2):483-92.
1996: Gregorio G V; Bracken P; Mieli-Vergani G; Vergani D
Prevalence of antibodies to hepatitis C and herpes simplex virus type 1 is not increased in children with liver kidney microsomal type 1 autoimmune hepatitis.
Journal of pediatric gastroenterology and nutrition 1996;23(5):534-7.
1996: Arif S; Vallian S; Farzaneh F; Zanone M M; James S L; Pietropaolo M; Hettiarachchi S; Vergani D; Conway G S; Peakman M
Identification of 3 beta-hydroxysteroid dehydrogenase as a novel target of steroid cell autoantibodies: association of autoantibodies with endocrine autoimmune disease.
The Journal of clinical endocrinology and metabolism 1996;81(12):4439-45.
1996: Peakman M; Leslie R D; Alviggi L; Hawa M; Vergani D
Persistent activation of CD8+ T-cells characterizes prediabetic twins.
Diabetes care 1996;19(11):1177-84.
1996: Mahalingam M; Pozniak A; McManus T J; Senaldi G; Vergani D; Peakman M
Abnormalities of CD45 isoform expression in HIV infection.
Clinical immunology and immunopathology 1996;81(2):210-4.
1996: Gregorio G V; Jones H; Choudhuri K; Vegnente A; Bortolotti F; Mieli-Vergani G; Vergani D
Autoantibody prevalence in chronic hepatitis B virus infection: effect in interferon alfa.
Hepatology (Baltimore, Md.) 1996;24(3):520-3.
1996: Vergani D; Mieli-Vergani G
Autoimmune hepatitis.
Annali italiani di medicina interna : organo ufficiale della Società italiana di medicina interna 1996;11(2):119-24.
1996: Hussain M J; Peakman M; Gallati H; Lo S S; Hawa M; Viberti G C; Watkins P J; Leslie R D; Vergani D
Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM.
Diabetologia 1996;39(1):60-9.
1996: Mieli-Vergani G; Vergani D
Autoimmune hepatitis.
Archives of disease in childhood 1996;74(1):2-5.
1995: Mahalingam M; Pozniak A; McManus T J; Vergani D; Peakman M
Cell cycling in HIV infection: analysis of in vivo activated lymphocytes.
Clinical and experimental immunology 1995;102(3):481-6.
1995: Gregorio G V; Davies E T; Mieli-Vergani G; Vergani D
Significance of extractable nuclear antigens in childhood autoimmune liver disease.
Clinical and experimental immunology 1995;102(2):308-13.
1995: Senaldi G; Davies E T; Peakman M; Vergani D; Lu J; Reid K B
Frequency of mannose-binding protein deficiency in patients with systemic lupus erythematosus.
Arthritis and rheumatism 1995;38(11):1713-4.
1995: Senaldi G; Davies E T; Mahalingam M; Lu J; Pozniak A; Peakman M; Reid K B; Vergani D
Circulating levels of mannose binding protein in human immunodeficiency virus infection.
The Journal of infection 1995;31(2):145-8.
1995: Ochola J; Hussain M; Khamashta M; Hughes G R; Vergani D
Detection of brain-reactive autoantibodies in the sera of patients with systemic lupus erythematosus and cerebral involvement.
Journal of immunological methods 1995;185(2):259-61.
1995: Porcel J M; Ordi J; Castro-Salomo A; Vilardell M; Rodrigo M J; Gene T; Warburton F; Kraus M; Vergani D
The value of complement activation products in the assessment of systemic lupus erythematosus flares.
Clinical immunology and immunopathology 1995;74(3):283-8.
1995: Han S; Tredger M; Gregorio G V; Mieli-Vergani G; Vergani D
Anti-liver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease.
Hepatology (Baltimore, Md.) 1995;21(1):58-62.
1995: Peakman M; Mahalingam M; Pozniak A; McManus T J; Phillips A N; Vergani D
Markers of immune cell activation and disease progression. Cell activation in HIV disease.
Advances in experimental medicine and biology 1995;374():17-26.
1994: Hussain M J; Lau J Y; Williams R; Vergani D
Hepatic expression of tumour necrosis factor-alpha in chronic hepatitis B virus infection.
Journal of clinical pathology 1994;47(12):1112-5.
1994: Hussain M J; Mustafa A; Gallati H; Mowat A P; Mieli-Vergani G; Vergani D
Cellular expression of tumour necrosis factor-alpha and interferon-gamma in the liver biopsies of children with chronic liver disease.
Journal of hepatology 1994;21(5):816-21.
1994: Zanone M M; Petersen J S; Peakman M; Mathias C J; Watkins P J; Dyrberg T; Vergani D
High prevalence of autoantibodies to glutamic acid decarboxylase in long-standing IDDM is not a marker of symptomatic autonomic neuropathy.
Diabetes 1994;43(9):1146-51.
1994: Mieli-Vergani G; Vergani D
Progress in pediatric autoimmune hepatitis.
Seminars in liver disease 1994;14(3):282-8.
1994: Ma Y; Peakman M; Lobo-Yeo A; Wen L; Lenzi M; Gäken J; Farzaneh F; Mieli-Vergani G; Bianchi F B; Vergani D
Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection.
Clinical and experimental immunology 1994;97(1):94-9.
1994: Smerdon R A; Peakman M; Hussain M J; Wong F S; Watkins P J; Leslie R D; Vergani D
CD5+ B-cells at the onset of type I diabetes and in the prediabetic period.
Diabetes care 1994;17(7):657-64.
1994: Mackie F D; Peakman M; Yun M; Sallie R; Smith H; Davies E T; Mieli-Vergani G; Vergani D
Primary and secondary liver/kidney microsomal autoantibody response following infection with hepatitis C virus.
Gastroenterology 1994;106(6):1672-5.
1994: Acunas B A; Peakman M; Liossis G; Davies E T; Bakoleas B; Costalos C; Gamsu H R; Vergani D
Effect of fresh frozen plasma and gammaglobulin on humoral immunity in neonatal sepsis.
Archives of disease in childhood. Fetal and neonatal edition 1994;70(3):F182-7.
1994: Peakman M; Alviggi L; Hussain M J; Lo S S; Hawa M; Leslie R D; Vergani D
Increased expression of T-cell markers of immunological memory associated with protection from type I diabetes. A study of identical twins.
Diabetes 1994;43(5):712-7.
1994: Tun R Y; Peakman M; Alviggi L; Hussain M J; Lo S S; Shattock M; Pyke D A; Bottazzo G F; Vergani D; Leslie R D
Importance of persistent cellular and humoral immune changes before diabetes develops: prospective study of identical twins.
BMJ (Clinical research ed.) 1994;308(6936):1063-8.
1994: Peakman M; Warnock T; Vats A; McNab G L; Underhill J; Donaldson P T; Vergani D
Lymphocyte subset abnormalities, autoantibodies and their relationship with HLA DR types in children with type 1 (insulin-dependent) diabetes and their first degree relatives.
Diabetologia 1994;37(2):155-65.
1994: Peakman M; Mahalingam M; Leslie R D; Vergani D
Co-expression of CD45RA (naive) and CD45R0 (memory) T-cell markers.
Lancet 1994;343(8894):424.
1994: Peakman M; McNab G L; Heaton N D; Tan K C; Vergani D
Development of techniques for obtaining monodispersed human islet cells.
Transplantation 1994;57(3):384-93.
1994: Senaldi G; Peakman M; Natoli C; Hussain M J; Gallati H; McManus T; Vergani D; Iacobelli S
Relationship between the tumour-associated antigen 90K and cytokines in the circulation of persons infected with human immunodeficiency virus.
The Journal of infection 1994;28(1):31-9.
1994: Peakman M; Wen L; McNab G L; Watkins P J; Tan K C; Vergani D
T cell clones generated from patients with type 1 diabetes using interleukin-2 proliferate to human islet antigens.
Autoimmunity 1994;17(1):31-9.
1994: Doherty D G; Underhill J A; Donaldson P T; Manabe K; Mieli-Vergani G; Eddleston A L; Vergani D; Demaine A G; Williams R
Polymorphism in the human complement C4 genes and genetic susceptibility to autoimmune hepatitis.
Autoimmunity 1994;18(4):243-9.
1993: Smerdon R A; Peakman M; Hussain M J; Vergani D
Lymphocyte vaccination prevents spontaneous diabetes in the non-obese diabetic mouse.
Immunology 1993;80(3):498-501.
1993: Mahalingam M; Peakman M; Davies E T; Pozniak A; McManus T J; Vergani D
T cell activation and disease severity in HIV infection.
Clinical and experimental immunology 1993;93(3):337-43.
1993: Peakman M; Leslie R D; Vergani D
Immunological studies on type 1 diabetes in identical twins.
Archives of disease in childhood 1993;69(1):97-9.
1993: Zanone M M; Peakman M; Purewal T; Watkins P J; Vergani D
Autoantibodies to nervous tissue structures are associated with autonomic neuropathy in type 1 (insulin-dependent) diabetes mellitus.
Diabetologia 1993;36(6):564-9.
1993: Peakman M; Tredger J M; Davies E T; Davenport M; Dunne J B; Williams R; Vergani D
Analysis of peripheral blood mononuclear cells in rodents by three-colour flow cytometry using a small-volume lysed whole blood technique.
Journal of immunological methods 1993;158(1):87-94.
1993: Porcel J M; Peakman M; Senaldi G; Vergani D
Methods for assessing complement activation in the clinical immunology laboratory.
Journal of immunological methods 1993;157(1-2):1-9.
1993: Smerdon R A; Peakman M; Hussain M J; Alviggi L; Watkins P J; Leslie R D; Vergani D
Increase in simultaneous coexpression of naive and memory lymphocyte markers at diagnosis of IDDM.
Diabetes 1993;42(1):127-33.
1992: Senaldi G; Portmann B; Mowat A P; Mieli-Vergani G; Vergani D
Immunohistochemical features of the portal tract mononuclear cell infiltrate in chronic aggressive hepatitis.
Archives of disease in childhood 1992;67(12):1447-53.
1992: Porcel J M; Vergani D
Complement and lupus: old concepts and new directions.
Lupus 1992;1(6):343-9.
1992: Peakman M; Buggins A G; Nicolaides K H; Layton D M; Vergani D
Analysis of lymphocyte phenotypes in cord blood from early gestation fetuses.
Clinical and experimental immunology 1992;90(2):345-50.
1992: Peakman M; Senaldi G; Liossis G; Gamsu H R; Vergani D
Complement activation in neonatal infection.
Archives of disease in childhood 1992;67(7 Spec No):802-7.
1992: Wen L; Peakman M; Mieli-Vergani G; Vergani D
Elevation of activated gamma delta T cell receptor bearing T lymphocytes in patients with autoimmune chronic liver disease.
Clinical and experimental immunology 1992;89(1):78-82.
1992: Doherty D G; Ireland R; Demaine A G; Wang F; Veerapan K; Welsh K I; Vergani D
Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus in southern Chinese.
Arthritis and rheumatism 1992;35(6):641-6.
1992: Peakman M; Senaldi G; Foote N; McManus T J; Vergani D
Naturally occurring soluble CD4 in patients with human immunodeficiency virus infection.
The Journal of infectious diseases 1992;165(5):799-804.
1991: Littleton E T; Bevis L; Hansen L J; Peakman M; Mowat A P; Mieli-Vergani G; Vergani D
Alpha 1-antitrypsin deficiency, complement activation, and chronic liver disease.
Journal of clinical pathology 1991;44(10):855-8.
1991: Hadzic N; Alberti A; Portmann B; Vergani D
Detection of hepatitis B virus pre-S1 and pre-S2 determinants in paraffin wax embedded liver tissue: importance of reagents used.
Journal of clinical pathology 1991;44(7):554-7.
1991: Jones H W; Ireland R; Senaldi G; Wang F; Khamashta M; Bellingham A J; Veerapan K; Hughes G R; Vergani D
Anticardiolipin antibodies in patients from Malaysia with systemic lupus erythematosus.
Annals of the rheumatic diseases 1991;50(3):173-5.
1991: Senaldi G; Lobo-Yeo A; Mowat A P; Mieli-Vergani G; Vergani D
Class I and class II major histocompatibility complex antigens on hepatocytes: importance of the method of detection and expression in histologically normal and diseased livers.
Journal of clinical pathology 1991;44(2):107-14.
1990: Wen L; Peakman M; Lobo-Yeo A; McFarlane B M; Mowat A P; Mieli-Vergani G; Vergani D
T-cell-directed hepatocyte damage in autoimmune chronic active hepatitis.
Lancet 1990;336(8730):1527-30.
1990: Senaldi G; Peakman M; McManus T; Davies E T; Tee D E; Vergani D
Activation of the complement system in human immunodeficiency virus infection: relevance of the classical pathway to pathogenesis and disease severity.
The Journal of infectious diseases 1990;162(6):1227-32.
1990: Bhaduri B R; Tan K C; Humphreys S; Williams R; Donaldson P; Vergani D; Mowat A P; Mieli-Vergani G
Graft-versus-host disease after orthotopic liver transplantation in a child.
Transplantation proceedings 1990;22(5):2378-80.
1990: Lobo-Yeo A; Senaldi G; Portmann B; Mowat A P; Mieli-Vergani G; Vergani D
Class I and class II major histocompatibility complex antigen expression on hepatocytes: a study in children with liver disease.
Hepatology (Baltimore, Md.) 1990;12(2):224-32.
1990: Lobo-Yeo A; Mieli-Vergani G; Mowat A P; Vergani D
Soluble interleukin 2 receptors in autoimmune chronic active hepatitis.
Gut 1990;31(6):690-3.
1990: Peakman M; Hussain M J; Millward B A; Leslie R D; Vergani D
Effect of initiation of insulin therapy on T-lymphocyte activation in type 1 diabetes.
Diabetic medicine : a journal of the British Diabetic Association 1990;7(4):327-30.
1990: Mahmud T; Peakman M; Senaldi G; McWhirter A; Black C M; Vergani D
Antireticulin antibody in systemic sclerosis.
Annals of the rheumatic diseases 1990;49(3):177-80.
1989: Senaldi G; Donaldson P T; Magrin S; Farrant J M; Alexander G J; Vergani D; Williams R
Activation of the complement system in primary sclerosing cholangitis.
Gastroenterology 1989;97(6):1430-4.
1989: Senaldi G; Lupoli S; Vergani D; Black C M
Activation of the complement system in systemic sclerosis. Relationship to clinical severity.
Arthritis and rheumatism 1989;32(10):1262-7.
1989: Peakman M; Senaldi G; Vergani D
Review: assessment of complement activation in clinical immunology laboratories: time for reappraisal?
Journal of clinical pathology 1989;42(10):1018-25.
1989: Senaldi G; Peakman M; McManus T; Davies E T; Tee D E; Vergani D
Classical complement pathway in HIV infection.
Lancet 1989;2(8663):624.
1989: Makinde V A; Senaldi G; Jawad A S; Berry H; Vergani D
Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
Annals of the rheumatic diseases 1989;48(4):302-6.
1989: Lobo-Yeo A; McSorley C; McFarlane B M; Mieli-Vergani G; Mowat A P; Vergani D
Detection of anti-liver cell membrane antibody using a human hepatocellular carcinoma cell line.
Hepatology (Baltimore, Md.) 1989;9(2):210-4.
1989: Mieli-Vergani G; Lobo-Yeo A; McFarlane B M; McFarlane I G; Mowat A P; Vergani D
Different immune mechanisms leading to autoimmunity in primary sclerosing cholangitis and autoimmune chronic active hepatitis of childhood.
Hepatology (Baltimore, Md.) 1989;9(2):198-203.
1989: Donaldson P T; Hussain M J; Mieli-Vergani G; Mowat A P; Vergani D
Anti-lymphocytic antibodies in autoimmune chronic active hepatitis starting in childhood.
Clinical and experimental immunology 1989;75(1):41-6.
1989: Peakman M; Bevis L; Mieli-Vergani G; Mowat A P; Vergani D
Double stranded DNA binding in autoimmune chronic active hepatitis and primary sclerosing cholangitis starting in childhood.
Autoimmunity 1989;3(4):271-80.
1988: Loftus B G; Price J F; Lobo-Yeo A; Vergani D
IgG subclass deficiency in asthma.
Archives of disease in childhood 1988;63(12):1434-7.
1988: Gilbey S G; Hussain M J; Watkins P J; Vergani D
Cell-mediated immunity and symptomatic diabetic autonomic neuropathy.
Diabetic medicine : a journal of the British Diabetic Association 1988;5(9):845-8.
1988: Senaldi G; Makinde V A; Vergani D; Isenberg D A
Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus.
Annals of the rheumatic diseases 1988;47(11):913-7.
1988: Johnston C; Alviggi L; Millward B A; Leslie R D; Pyke D A; Vergani D
Alterations in T-lymphocyte subpopulations in type I diabetes. Exploration of genetic influence in identical twins.
Diabetes 1988;37(11):1484-8.
1988: Senaldi G; Millward B A; Hussain M J; Pyke D A; Leslie R D; Vergani D
Low serum haemolytic function of the fourth complement component (C4) in insulin dependent diabetes.
Journal of clinical pathology 1988;41(10):1114-6.
1988: Senaldi G; Ireland R; Bellingham A J; Vergani D; Veerapan K; Wang F
IgM reduction in systemic lupus erythematosus.
Arthritis and rheumatism 1988;31(9):1213.
1988: Davies E T; Nasaruddin B A; Alhaq A; Senaldi G; Vergani D
Clinical application of new technique that measures C4d for assessment of activation of classical complement pathway.
Journal of clinical pathology 1988;41(2):143-7.
1988: Millward A; Hussain M J; Peakman M; Pyke D A; Leslie R D; Vergani D
Characterization of islet cell antibody in insulin dependent diabetes: evidence for IgG1 subclass restriction and polyclonality.
Clinical and experimental immunology 1988;71(2):353-6.
1987: Vergani D; Mieli-Vergani G; Mondelli M; Portmann B; Eddleston A L
Immunoglobulin on the surface of isolated hepatocytes is associated with antibody-dependent cell-mediated cytotoxicity and liver damage.
Liver 1987;7(6):307-15.
1987: Hussain M J; Alviggi L; Millward B A; Leslie R D; Pyke D A; Vergani D
Evidence that the reduced number of natural killer cells in type 1 (insulin-dependent) diabetes may be genetically determined.
Diabetologia 1987;30(12):907-11.
1987: Peakman M; Lobo-Yeo A; Senaldi G; Nilsson M; Tee D E; Vergani D
Quantification of C3d in biological fluids by an enzyme-linked immunosorbent assay.
Journal of immunological methods 1987;104(1-2):51-6.
1987: Senaldi G; Peakman M; Alhaq A; Makinde V A; Tee D E; Vergani D
Activation of the alternative complement pathway: clinical application of a new technique to measure fragment Ba.
Journal of clinical pathology 1987;40(10):1235-9.
1987: Senaldi G; Millward B A; Hussein M J; Pyke D; Leslie R D; Vergani D
Complement in type 1 (insulin-dependent) diabetes.
Diabetologia 1987;30(10):823.
1987: Peakman M; Lobo-Yeo A; Mieli-Vergani G; Davies E T; Mowat A P; Vergani D
Characterization of anti-liver kidney microsomal antibody in childhood autoimmune chronic active hepatitis: evidence for IgG1 subclass restriction, polyclonality and non cross-reactivity with hepatocyte surface antigens.
Clinical and experimental immunology 1987;69(3):543-9.
1986: Gilbey S G; Guy R J; Jones H; Vergani D; Watkins P J
Diabetes and autonomic neuropathy: an immunological association?
Diabetic medicine : a journal of the British Diabetic Association 1986;3(3):241-5.
1986: Millward B A; Alviggi L; Hoskins P J; Johnston C; Heaton D; Bottazzo G F; Vergani D; Leslie R D; Pyke D A
Immune changes associated with insulin dependent diabetes may remit without causing the disease: a study in identical twins.
British medical journal (Clinical research ed.) 1986;292(6523):793-6.
1986: McFarlane B M; McSorley C G; Vergani D; McFarlane I G; Williams R
Serum autoantibodies reacting with the hepatic asialoglycoprotein receptor protein (hepatic lectin) in acute and chronic liver disorders.
Journal of hepatology 1986;3(2):196-205.
1985: Vergani D; Wells L; Larcher V F; Nasaruddin B A; Davies E T; Mieli-Vergani G; Mowat A P
Genetically determined low C4: a predisposing factor to autoimmune chronic active hepatitis.
Lancet 1985;2(8450):294-8.
1984: Alviggi L; Johnston C; Hoskins P J; Tee D E; Pyke D A; Leslie R D; Vergani D
Pathogenesis of insulin-dependent diabetes: a role for activated T lymphocytes.
Lancet 1984;2(8393):4-6.
1980: Vergani D; Morgan-Capner P; Davies E T; Anderson A W; Tee D E; Pattison J R
Joint symptoms, immune complexes, and rubella.
Lancet 1980;2(8189):321-2.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Diego Vergani

Research Profile (preview)

Chemicals & Drugs

Disorders

Anatomy

Physiology

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Diego Vergani (preview)

All Publications